BLTE logo

BLTE
Belite Bio Inc

273
Mkt Cap
$5.72B
Volume
256,584.00
52W High
$200.00
52W Low
$56.10
PE Ratio
-62.23
BLTE Fundamentals
Price
$143.00
Prev Close
$149.95
Open
$149.77
50D MA
$161.90
Beta
0.68
Avg. Volume
134,781.77
EPS (Annual)
-$2.31
P/B
7.30
Rev/Employee
$0.00
$4,872.77
Loading...
Loading...
News
all
press releases
Nathan Mata Sells 1,000 Shares of Belite Bio (NASDAQ:BLTE) Stock
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) insider Nathan Mata sold 1,000 shares of Belite Bio stock in a transaction on Tuesday, May 5th. The stock was sold at an average price...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Belite Bio (BLTE) Projected to Post Quarterly Earnings on Tuesday
Belite Bio (NASDAQ:BLTE) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-belite-bio-inc-stock...
MarketBeat·12d ago
News Placeholder
Insider Selling: Belite Bio (NASDAQ:BLTE) Insider Sells 1,000 Shares of Stock
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) insider Nathan Mata sold 1,000 shares of the firm's stock in a transaction on Wednesday, April 29th. The shares were sold at an average...
MarketBeat·16d ago
News Placeholder
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight research firms that are presently covering the firm...
MarketBeat·16d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Insider Nathan Mata Sells 1,000 Shares
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) insider Nathan Mata sold 1,000 shares of the company's stock in a transaction dated Wednesday, April 29th. The shares were sold at an...
MarketBeat·16d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Insider Sells $162,640.00 in Stock
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) insider Nathan Mata sold 1,000 shares of the firm's stock in a transaction dated Monday, April 27th. The stock was sold at an average...
MarketBeat·18d ago
News Placeholder
Belite Bio Shares Tinlarebant Phase III Stargardt Data, FDA Rolling Submission at DB Conference
Belite Bio (NASDAQ:BLTE) highlighted progress for its lead drug candidate tinlarebant during the 30th Deutsche Bank Depositary Receipts Virtual Investor Conference, outlining late-stage clinical...
MarketBeat·19d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Insider Sells $159,560.00 in Stock
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) insider Nathan Mata sold 1,000 shares of the firm's stock in a transaction on Friday, April 24th. The stock was sold at an average price...
MarketBeat·19d ago
News Placeholder
Nathan Mata Sells 1,000 Shares of Belite Bio (NASDAQ:BLTE) Stock
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) insider Nathan Mata sold 1,000 shares of the company's stock in a transaction on Wednesday, April 22nd. The stock was sold at an average...
MarketBeat·23d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Insider Nathan Mata Sells 1,000 Shares
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) insider Nathan Mata sold 1,000 shares of Belite Bio stock in a transaction dated Wednesday, April 22nd. The shares were sold at an...
MarketBeat·23d ago
<
1
2
...
>

Latest BLTE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.